Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research.
vom Saal
Frederick S
FS
Akingbemi
Benson T
BT
Belcher
Scott M
SM
Crain
David A
DA
Crews
David
D
Guidice
Linda C
LC
Hunt
Patricia A
PA
Leranth
Csaba
C
Myers
John Peterson
JP
Nadal
Angel
A
Olea
Nicholas
N
Padmanabhan
Vasantha
V
Rosenfeld
Cheryl S
CS
Schneyer
Alan
A
Schoenfelder
Gilbert
G
Sonnenschein
Carlos
C
Soto
Ana M
AM
Stahlhut
Richard W
RW
Swan
Shanna H
SH
Vandenberg
Laura N
LN
Wang
Hong-Sheng
HS
Watson
Cheryl S
CS
Welshons
Wade V
WV
Zoeller
Robert T
RT
D000818:Animals; D004305:Dose-Response Relationship, Drug; D052244:Endocrine Disruptors / Q000633:toxicity*; D004968:Estrogens, Non-Steroidal / Q000633:toxicity*; D004997:Ethinyl Estradiol / Q000633:toxicity; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005836:Genitalia, Female / Q000002:abnormalities / Q000187:drug effects; D017408:Guidelines as Topic; D008297:Male; D018811:Maternal Exposure; D019055:No-Observed-Adverse-Effect Level; D011247:Pregnancy; D051381:Rats; D020318:Rats, Long-Evans; D012107:Research Design / Q000592:standards*; D018675:Toxicity Tests / Q000379:methods / Q000592:standards
D052244:Endocrine Disruptors; D004968:Estrogens, Non-Steroidal; D004997:Ethinyl Estradiol